Skip to search formSkip to main contentSkip to account menu

L 163017

Known as: L 163,017, L-163,017, L-163017 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

Angiotensin Receptor AntagonistsImidazolesPyridines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Balanced affinity AT1/AT2 receptor nonpeptide binding site determinants on the AT1 angiotensin receptor.
Angiotensin II (Ang II), a potent modulator of cardiovascular homeostasis, mediates its effects through two Ang II receptor… 
1996
1996
Identification of nonconserved amino acids in the AT1 receptor which comprise a general binding site for biphenylimidazole antagonists
1995
1995
In vitro pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for AT2 receptors.
1995
1995
In vivo pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for AT2 receptors.
L-163,017 (6-[benzoylamino]-7-methyl-2-propyl-3-[[2'-(N-(3-methyl-1-butoxy) carbonylaminosulfonyl)[1,1']-biphenyl-4-yl]methyl]-3H… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)